ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Sino Biopharmaceutical Limited clinical trials

Also known as CTTQ, Sino Biopharm.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 471 studies whose lead sponsor is Sino Biopharmaceutical Limited or one of 14 companies grouped under it. 163 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

Our grouping of 14 registry names, not the registry’s. See them and correct one ↓

Compare Sino Biopharmaceutical with Hoffmann-La Roche and BeOne Medicines →

Pipeline: 97 programs

Each counted once: 72 with a study Sino Biopharmaceutical Limited leads registered in the last two years, 25 more from Sino Biopharmaceutical Limited's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)
  • Named by Sino Biopharmaceutical Limited only (no registered study yet; not in the 97)

The 5 of 26 with the most live studies.

Program
Anti-HER2/Topoisomerase I Inhibitor ADC TQB2102Phase 3 · Sino Biopharmaceutical Limited: Phase 3 · 12 live · Breast Neoplasms · primary completion Jan 2027☆ Track
benmelstobartTQB2450Phase 3 · 9 live · Carcinoma, Non-Small-Cell Lung · primary completion Dec 2027☆ Track
penpulimabPhase 3 · 7 live · Carcinoma, Hepatocellular · primary completion Dec 2026☆ Track
NTQ5082Phase 3 · 6 live · Hemoglobinuria, Paroxysmal · primary completion Nov 2026☆ Track
culmerciclibTQB3616Phase 3 · Sino Biopharmaceutical Limited: Registration · 5 live · Breast Neoplasms · primary completion Dec 2026☆ Track

21 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Sino Biopharmaceutical Limited’s own registered studies; “Sino Biopharmaceutical Limited says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Sino Biopharmaceutical Limited’s studies test, most open studies first — 93 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 93; every drug is on its own page, and each page lists its sponsors.

Coming up

57 of Sino Biopharmaceutical Limited’s studies under way reach primary completion within a year, 15 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 4N’26
  2. 17D
  3. 3J’27
  4. 2F
  5. 5M
  6. 3A
  7. 2M
  8. 4J
  9. 2J
  10. 8A
  11. 3S
  12. 2O
  13. 2N

The 12 nearest

Show 7 more

Add all 57 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 20, 2026.

All 471 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now16335%Recruiting 106 · Not yet recruiting 51 · Enrolling by invitation 6
  • Under way, not recruiting317%
  • Completed9119%
  • Stopped early449%Terminated 39 · Withdrawn 4 · Suspended 1
  • Status unknown or other14230%

Phase

Where

  • China444
  • Australia9
  • United States6
  • Spain2
  • Georgia1
  • Poland1

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 6824
  19. 25
  20. 4926

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sino Biopharmaceutical Limited.

  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    320 studies →
  • Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    53 studies →
  • Nanjing Chia-tai Tianqing Pharmaceutical
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    19 studies →
  • Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    18 studies →
  • LaNova Medicines Limited
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    18 studies →
  • Beijing Tide Pharmaceutical Co., Ltd
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    14 studies →
  • Cttq
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →
  • Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • invoX Pharma Limited
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • LaNova Medicines Zhejiang Co., Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • LaNova Australia Pty Limited
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • LaNova Medicines Development Co., Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Sino Biopharmaceutical Limited leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 471. Browse all 471 →